Fusen Pharmaceutical Company Limited (1652.HK) HKSE

0.79

+0(+0.00%)

Updated at December 05 03:59PM

Currency In HKD

Valuation

Market Cap555.99M
Enterprise Value918.63M
P/E Ratio-2.95
PEG Ratio-0.37
Price/Sales Ratio2.14
Price/Book Ratio1.49
Enterprise/Revenue3.34
Enterprise/EBITDA-44.84

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.73
Operating Margin-0.21

Management Effectiveness

Return On Assets-0.14
Return On Equity-0.49

Income Statement

Revenue326.03M
Revenue/Share0.33
Gross Profit162.64M
EBITDA-39.07M
Net Income-188.78M
Diluted EPS-0.26

Balance Sheet

Total Cash75.99M
Total Cash/Share0.1
Total Debt364.67M
Total Debt/Equity1.05
Current Ratio0.57
Book Value Per Share0.47

Price History

52-Week Change-16.3
52-Week High1.75
52-Week Low0.24
Moving Average 50 Days0.79
Moving Average 200 Days0.46

Statistics

Average Volume2.57M
Shares Outstanding739.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A